EC Number   |
Title |
Organism |
|---|
   2.1.1.320 | Caenorhabditis elegans PRMT-7 and PRMT-9 are evolutionarily conserved protein arginine methyltransferases with distinct substrate specificities |
Caenorhabditis elegans |
| 2.1.1.320 | Characterization of protein arginine methyltransferase of TgPRMT5 in Toxoplasma gondii |
Toxoplasma gondii |
| 2.1.1.320 | Characterization of protein arginine methyltransferase of TgPRMT5 in Toxoplasma gondii |
Toxoplasma gondii ATCC 50853 |
| 2.1.1.320 | Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase expression by decreasing the Sp1 and NF-YA transcription factors in the A549 and MCF-7 cells |
Homo sapiens |
| 2.1.1.320 | Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors |
Homo sapiens |
| 2.1.1.320 | Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases |
Homo sapiens |
| 2.1.1.320 | KAP1 is a novel substrate for the arginine methyltransferase PRMT5 |
Homo sapiens |
| 2.1.1.320 | Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors |
Homo sapiens |
| 2.1.1.320 | Protein arginine methyltransferase 5 (PRMT5) as an anticancer target and its inhibitor discovery |
Homo sapiens |
| 2.1.1.320 | Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/?-catenin and AKT/GSK3? proliferative signaling |
Homo sapiens |
